Objectives: The study examined whether patients who responded to an antidepressant in one episode of depression responded to the same agent in a subsequent episode. It also sought to determine whether in a subsequent episode clinicians prescribed an antidepressant that had previously been effective.
Methods: Charts of inpatients with a diagnosis of major depression who were consecutively admitted to general hospital psychiatric wards were screened to determine whether the patients met the inclusion criteria of recurrent major depression and had responded to antidepressant therapy in a previous episode. Data were collected on type of treatment and treatment response for each episode.
Results: Fifty-nine patients met the inclusion criteria. Thirty-five of the patients (59.3 percent) were prescribed the same antidepressant in both the current and previous episodes. Of these, 20 patients responded and 15 did not. Of the 24 patients who did not receive the same antidepressant, 14 were attended by the same clinician in both treatment episodes. Nineteen of the 24 patients responded to a new antidepressant, and five did not.
Conclusions: Patients with recurrent depression are often prescribed antidepressants other than those that were effective in previous treatment episodes. Use of a previously effective antidepressant may not increase the treatment response rate in a subsequent depressive episode.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1176/ps.45.4.359 | DOI Listing |
Epidemiol Psychiatr Sci
January 2025
Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, Center for Global Mental Health, King's College London, London, UK.
In low- and middle-income countries, fewer than 1 in 10 people with mental health conditions are estimated to be accurately diagnosed in primary care. This is despite more than 90 countries providing mental health training for primary healthcare workers in the past two decades. The lack of accurate diagnoses is a major bottleneck to reducing the global mental health treatment gap.
View Article and Find Full Text PDFAJNR Am J Neuroradiol
January 2025
From the Department of Radiology (P.C.F., A.P.S., J.J.Y.).
Background And Purpose: There is surging interest in the therapeutic potential of psychedelic compounds like psilocybin in the treatment of psychiatric illnesses like major depressive disorder (MDD). Recent studies point to the rapid antidepressant effect of psilocybin; however, the biological mechanisms underlying these differences remain unknown. This study determines the feasibility of using diffusion MRI to characterize and define the potential spatiotemporal microstructural differences in the brain following psilocybin treatment in C57BL/6J male mice.
View Article and Find Full Text PDFObstet Gynecol Clin North Am
March 2025
Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045, USA. Electronic address:
The hormonal changes that accompany the transition to menopause are disruptive to most women, and for some, mental health maybe adversely affected. Depressive symptoms and major depression are the best-studied conditions in association with menopause, but anxiety, executive function, and comorbid pre-existing psychiatric conditions all influence the symptomatology that women will experience during this phase of their lives. The epidemiology, diagnosis, and evidence-based treatment guidelines for perimenopausal patients are discussed.
View Article and Find Full Text PDFObstet Gynecol Clin North Am
March 2025
Department of Obstetrics and Gynecology, Montefiore Albert Einstein College of Medicine. Electronic address:
This is a review of the existing literature and guidelines for the screening, management, and follow-up of perinatal mood and anxiety disorders, with a focus on major depressive disorder and generalized anxiety disorder.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!